介入治疗巨大超巨大肝癌71例分析  

An Analysis of Interventionat Treatment in 71 Cases with Giant and Supergiant Hepatic Cancer

作　　者：刘增荣[1] 吴晗[1] 贺俊花[1] 李向东[1] 宗广胜[1] 董毅[1] 林剑平[1] 罗秀珍[1] 

机构地区：[1]内蒙古鄂尔多斯市中心医院,017000

出　　处：《现代医用影像学》2003年第4期148-149,共2页Modern Medical Imageology

摘　　要：目的:分析巨大超巨大肝癌动脉灌注化疗与栓塞的临床效果。材料与方法:71例巨大超巨大肝癌按Seldinger法进行血管造影了解肿瘤血供后,超选择性插管至肿瘤供血动脉进行灌注与栓塞治疗。结果:灌注与栓塞术后病灶均有不同程度的缩小,全部病例临床症状明显改善。其中半年生存率为97％(69/71),一年生存率63％(45/71)。二年生存率21％(15/71),三年生存率3％(2/71)。结论:采用动脉灌注化疗与栓塞是治疗巨大超巨大肝癌的一种有效方法,亦是综合治疗的重要手段,特别是对已有转移的病例,同时行转移瘤的介入治疗具有重要价值。Analyzing the clinical effect of TACE therapy of Giant and Supergiant Hepatic cancer. Materials and Methods: Seventy one cases of Giant and Supergiant Hepatic Cancer, blood supply were measured by seldinger angiography technology. Infusion and embo-lization therapy was carried through super selective intubation to the supply artery of tumar. Results: All cases symptoms were improved. All tumer's diameter decreased obviously after treatment of arterial infusion and embolization therapy, Half a year's existence ratio of patients is 97% (69/71), one year's existence ratio is 63% (45/71), two year's existence ratio is 21% (15/71), three year's existence ratio is 3% (2/71). Conclusion: The therapy of arterial infusion nad embolization is an effective treatment of Giant and Supergiant Hepatic cancer especially to meta-static cases, There is important value of interventional therapy for primary and metastatic malignancies at the sametime.

关 键 词：大肝癌 巨大 生存率 介入治疗 栓塞 动脉灌注化疗 肿瘤供血动脉 改善 目的 

分 类 号：R735.7[医药卫生—肿瘤]